Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
JHEP Reports : Innovation in Hepatology|January 23, 2023
Spatial molecular and cellular determinants of STAT3 activation in liver fibrosis progression in non-alcoholic fatty liver diseaseJingjing Jiao, Jessica I Sanchez, Omar A Saldarriaga, et al.Cancers|June 10, 2023
Cellular and Molecular Mechanisms of Liver Fibrosis in Patients with NAFLDJessica I Sanchez, Edwin R Parra, Jingjing Jiao, et al.International Journal of Molecular Sciences|July 24, 2021
Somatic Mutations in Circulating Cell-Free DNA and Risk for Hepatocellular Carcinoma in HispanicsJingjing Jiao, Jessica I Sanchez, Erika J Thompson, et al.Cancer Prevention Research (Philadelphia, Pa.)|July 13, 2021
Lipidomic Profiles of Plasma Exosomes Identify Candidate Biomarkers for Early Detection of Hepatocellular Carcinoma in Patients with CirrhosisJessica I Sanchez, Jingjing Jiao, Suet-Ying Kwan, et al.JHEP Reports : Innovation in Hepatology|August 14, 2024
Metabolomics biomarkers of hepatocellular carcinoma in a prospective cohort of patients with cirrhosisJessica I Sanchez, Antoine C Fontillas, Suet-Ying Kwan, et al.Hepatology Communications|June 9, 2025
Blood bacterial DNA signatures in a prospective cohort of patients with MASLD cirrhosisSuet-Ying Kwan, Lillian I Dolapchiev, Caren I Sanchez, et al.Medrxiv : the Preprint Server for Health Sciences|March 3, 2023
Patients with fibrosis from non-alcoholic steatohepatitis have heterogeneous intrahepatic macrophages and therapeutic targetsOmar A Saldarriaga, Santhoshi Krishnan, Timothy G Wanninger, et al.Medrxiv : the Preprint Server for Health Sciences|December 3, 2025
Developing a Fully Automated Imaging Biomarker for HCC Risk Assessment via MRI-Based Tumor Segmentation and EPMAwj Twam, Shane A Smith, Mohamed Eltaher, et al.Scientific Reports|June 9, 2026
Developing a fully automated imaging biomarker for HCC risk assessment via MRI-based tumor segmentation and EPMAwj Twam, Shane A Smith, Mohamed Eltaher, et al.JHEP Reports : Innovation in Hepatology|January 1, 2024
Heterogeneity in intrahepatic macrophage populations and druggable target expression in patients with steatotic liver disease-related fibrosisOmar A Saldarriaga, Timothy G Wanninger, Esteban Arroyave, et al.Pageof 2